power in civil suits according to article 177 of the RF Civil Code. ...... Ocarina app on the iPhone (http://ocarina.smule.com), which involved distant blowing into ...
Volume
1
Topics Volume 1 1. ADHD . . . . . . . . . . . . . . . . . . . . . . . . . . 2 Addiction . . . . . . . . . . . . . . . . . . . . . . . 3. Anxiety, Stress & Adjustment Disorders . . . . . . . . . . . . . . . . . . . . . . . 4. Art and Psychiatry . . . . . . . . . . . . . . . . 5. Biological Psychiatry & Neuroscience.
Page
9 133 327 437 461
Page Volume 2 6. Brain and Pain . . . . . . . . . . . . . . . . . . 9 7. Child & Adolescent Mental & Behavioral Disorders . . . . . . . . . . . . . 19 8. Conflict Management & Resolution . . 195 9. Dementia, Delirium and Related Cognitive Disorders . . . . . . . . . . . . . . 201 10. Diagnostic Systems . . . . . . . . . . . . . . . 281 11. Disasters & Emergencies in Psych. . . . 297 12. Dissociative, Somatization & Factitious Disorders . . . . . . . . . . . . . . . 307
Topics Page
14. 15. 16. 17.
Eating Disorders . . . . . . . . . . . . . . . . . . 331 Ecology, Psychiatry & Mental Health. . 399 Epidemiology and Public Health. . . . . . 405 Ethics, Law, Human Rights & Mental Health . . . . . . . . . . . . . . . . . . . 499
Page Volume 3 18. Evolutionary Psychiatry . . . . . . . . . . . 9 19. E xercise Psychiatry and Sports . . . . . . 17 20. Family Research, Intervention & Interdisciplinary Collaboration . . . . . . 33 21. Forensic Psychiatry . . . . . . . . . . . . . . . . 65 22. Genetic Psychiatry . . . . . . . . . . . . . . . . 117 23. Geriatric Psychiatry . . . . . . . . . . . . . . . 139 24. History and Psychiatry . . . . . . . . . . . . . 191 25. HIV and Psychiatry . . . . . . . . . . . . . . . . 221 26. Human Development . . . . . . . . . . . . . . 243
abstracts - volume 1
Topics Page
27. 28. 29. 30. 31. 32. 33.
Human Sexuality . . . . . . . . . . . . . . . . . . 253 Immunology and Psychiatry . . . . . . . . . 259 Impulse – Control Disorders . . . . . . . . . 275 Learning Disorders . . . . . . . . . . . . . . . . 285 Literature and Mental Health. . . . . . . . 293 Mass Media and Mental Health. . . . . . 299 Measurement Instruments in Psychiatric Care . . . . . . . . . . . . . . . . . . 307 34. Mental Health, Economics & Services Research . . . . . . . . . . . . . . . . . 331 35. Military Psychiatry . . . . . . . . . . . . . . . . 365 36. Miscellaneous . . . . . . . . . . . . . . . . . . . . 377 Page Volume 4 37. Mood Disorders . . . . . . . . . . . . . . . . . 9 38. Neural Sciences . . . . . . . . . . . . . . . . . . 177 39. Neuroimaging in Psychiatry . . . . . . . . 195
Topics Page
40. Neuropsychiatry and Behavioral Neurology . . . . . . . . . . . . . . . . . . . . . . . 41. Occupational Psychiatry, Psychiatric Rehabilitation . . . . . . . . . . . . . . . . . . . . 43. Personality and Psychopathology . . . . 44. Personality Disorders & Accentuated Personality . . . . . . . . . . . 45. Pharmacotherapies . . . . . . . . . . . . . . . 46. Philosophy and Humanities in Psychiatry . . . . . . . . . . . . . . . . . . . . . . .
247 307 329 357 385 501
Page Volume 5 47. Prevention and Health Promotion . . . 9 48. Primary Care and Mental Health . . . . . 51 49. Psychiatric Classification . . . . . . . . . . . 103 50. Psychiatry Education and Training . . . 109 51. Psychiatry in Developing Regions . . . . 139
abstracts - volume 1
Topics Page
52. Psychiatry in Private Practice . . . . . . . 53. Psychoanalysis in Psychiatry . . . . . . . . 54. Psychological Consequences of Torture and Persecution . . . . . . . . . . . 55. Psychological Sciences . . . . . . . . . . . . . 56. Psychoneurobiology . . . . . . . . . . . . . . 57. Psychoneuroendocrinology . . . . . . . . 58. Psycho-Oncology & Palliative Care . . . 59. Psychophysiology in Psychiatry . . . . . . 60. Psychosomatic Disorders . . . . . . . . . . . 61. Psychotherapies. . . . . . . . . . . . . . . . . . 62. Public Psychiatry . . . . . . . . . . . . . . . . . 63. Quality Assurance in Psychiatry . . . . . 64. Religion, Spirituality and Psychiatry. . . 65. Research Methods in Psychiatry . . . . . 66. Rural Mental Heath . . . . . . . . . . . . . . .
171 175 189 199 213 225 239 259 273 317 389 405 423 449 473
Topics Page Volume 6 67. Schizophrenia & Psychotic Disorders . 9 68. Sexual & Gender Identity Disorders . . 287 69. Sleep Disorders . . . . . . . . . . . . . . . . . . 311 70. Social and Cultural Psychiatry . . . . . . . 329 71. Sociotherapies . . . . . . . . . . . . . . . . . . . 381 72. Stigma and Mental Health . . . . . . . . . . 385 73. Suicide and Psychiatric Emergencies. . 435 74. Urban Mental Health . . . . . . . . . . . . . . 527 75. Women’s Mental Health . . . . . . . . . . . 537
abstracts - volume 1
Topic s
ADHD
abstracts - volume 1
1 .
XVI World Congress of Psychiatry. Madrid 2014
VOL. 1 - TOPIC 1: ADHD
CHARACTERISTICS OF HOSPITALIZED PATIENTS FOLLOWING SUICIDE ATTEMPT IN HAMADAN DISTRICT, IRAN Ali Ghaleih, Saeed Afzali Research Center For Behavioral Disorders And Substance Abuse, Hamadan University Of Medical Sciences. Hamedan. Iran
Objectives: Limited research has been undertaken on suicide in developing countries. This paper aims to investigate characteristics of suicide attempts in Hamadan district of Iran. Methods: A prospective study was conducted in all university hospitals in the Hamadan district of Iran and patients admitted for attempted suicides were included. All cases were assessed by psychiatrists and visited by two trained interns of Medicine. Results: The incidence rate per 100,000 persons of attempted suicides was 228.6 for males and 263.1 for females; moreover, 344.9 for rural areas and 222.7 for urban areas. The suicide attempt was the highest in the 15 to 24 age category for both sexes and regions. Conclusions: Suicide is a complex, long-term outcome that requires multifaceted theoretical constructs for the appropriate study of its antecedents. Findings of this study along with other studies in Iran revealed that unemployed men, housewives, and rural women, high-school students, and those with a low level of education were at higher risk of suicidal behaviors. Keywords: Suicide; Attempted suicide; Iran.
www.wpamadrid2014.com
ABSTRACTS BOOK
10
XVI World Congress of Psychiatry. Madrid 2014
VOL. 1 - TOPIC 1: ADHD
AFFECTIVE NETWORK HYPERCONNECTIVITY AND HYPOCONNECTIVITY OF COGNITIVE CONTROL AND VENTRAL ATTENTION NETWORKS IN ADULTS WITH HIGH NEUROTICISM SCORES ¹Carballedo A., ¹Doyle M., ²Lavelle G., ¹Amico F., ¹Sojo J., ¹McCarthy H., ²Gormely J., ¹O’Keane V., ¹Frodl T. ¹Department of Psychiatry and Trinity College Institute of Neuroscience, Trinity College Dublin, Ireland ²Department of Physiotherapy, St. James’s Hospital and Trinity College Dublin
Introduction: Subjects with high neuroticism are more likely to interpret ordinary situations as negative, and this might contribute to a predisposition toward mood and anxiety disorders. The aim of our study was to determine the localization of neuroticism-related resting state functional connectivity (RSFC) differences between the two groups of high and low neuroticism, and to confirm our hypothesis that subjects with high neuroticism show hyperconnectivity in the affective network and hypoconnectivity in the cognitive control and attention networks. Methods: Forty three healthy participants underwent resting state fMRI and completed the NEO Five Factor Personality Inventory. SPM8 and CONN software was used to pre-process and analyse resting state fMRI data. Correlation maps were produced between seed regions of the affective, cognitive control, attention and default mode networks and differences were analysed between groups fully corrected for multiple testing across the whole brain. Results: Participants with high neuroticism scores displayed significantly greater functional connectivity in the affective network. There was significantly less functional connectivity in the cognitive control network and ventral attention network for participants with high neuroticism scores when compared to those with low neuroticism scores. Discussion: Affective network hyperconnectivity might be related to emotional problems or mood disorders that are associated with high neuroticism. Additionally, the hypoconnectivity seen in the cognitive control network might have to do with inattention and cognitive deficits that have consistently been found in major depression and anxiety disorders. Thus, oversensitivity in affective systems and at the same time reduced cognitive control might be in line with increased stress sensitivity and emotional lability in subjects with high neuroticism.
www.wpamadrid2014.com
ABSTRACTS BOOK
11
XVI World Congress of Psychiatry. Madrid 2014
VOL. 1 - TOPIC 1: ADHD
LONG-TERM OUTCOMES OF ATTENTIONDEFICIT/HYPERACTIVITY DISORDER (ADHD) IN SPAIN: A SYSTEMATIC REVIEW AND REGIONAL COMPARISON J. Quintero 1, S. Young 2, H. Caci 3, J. Kahle 4, S. Plaza 5, G. Algorta, 6 1 . Psychiatry Department, Hospital Universitario Infanta Leonor, Madrid, Spain 2 . Imperial College London, Centre for Mental Health, UK 3 . Child and Adolescent Psychiatry Hôpitaux Pédiatriques de Nice, France 4 . BPS International, San Diego, California, USA 5 . Shire, Madrid, Spain 6 . The Ohio State University, Ohio, USA
Objectives: Attention-deficit/hyperactivity disorder (ADHD) is increasingly recognized worldwide as an important psychiatric condition of which the long-term outcomes affect the patient, their family, and society. This analysis identified studies of long-term outcomes (≥2 years) of ADHD in Spain and compared the outcomes with Latin America, Rest of Europe (ROE), Northern America, and Rest of World (ROW). Methods: A systematic literature search was performed using Cochrane guidelines for primary, peer-reviewed studies (published 1/1980-12/2011 in English-language) reporting long-term outcomes (≥2 years) of ADHD. Results: 403 studies were included; 4 from Spain, 4 from Latin America (Brazil, Colombia, Mexico, Puerto Rico), 76 from ROE, 292 from Northern America (USA, Canada), and 400 from ROW. Study designs, settings, diagnostics, measures, and populations varied. Outcomes comprised 9 groups: academics, antisocial behavior, driving, non-medicinal drug use/addictive behavior, obesity, occupation, self-esteem, services use, and social function. A high percentage (83%) of poor long-term outcomes was reported for untreated ADHD in Spain. This result was very similar in Latin America, ROE, Northern America, and ROW for untreated ADHD. Five of the 9 outcome groups were studied in Spain. No studies from Spain were of treatment outcomes, but ROW results showed a high proportion of long-term outcomes improved with ADHD treatment. Conclusions: The results of studies of long-term outcomes of ADHD were similar in Spain and Latin America, ROE, Northern America, and ROW. ROW results show improved outcomes with ADHD treatment, thus Spain-based studies of long-term outcomes of ADHD treatment should be considered. Study funding from Shire Development.
www.wpamadrid2014.com
ABSTRACTS BOOK
12
XVI World Congress of Psychiatry. Madrid 2014
VOL. 1 - TOPIC 1: ADHD
WHAT IS A CLINICALLY RELEVANT IMPROVEMENT IN QUALITY OF LIFE IN ADULTS WITH ATTENTION DEFICIT/HYPERACTIVITY DISORDER? Yoko Tanaka, PhD1; Meryl Brod, PhD2; Jeannine R. Lane, PhD3; Himanshu Upadhyaya, MBBS, MS1 1 Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN, USA 46285 2 The Brod Group, Mill Valley, CA, USA 94941 3 inVentiv Health, Indianapolis, IN, USA 46280
Objective(s): To estimate a minimal clinically important difference (MCID) on the adult attention-deficit/hyperactivity disorder (ADHD) Quality of Life (AAQoL) scale using anchorand distribution-based methodologies. Methods: Data were pooled from 3 short-term (N=537) and 2 long-term (N=440) placebocontrolled trials of atomoxetine in adults with ADHD. For the anchor-based approach, patients were categorized into much-improvement (-5 to -2), slight-improvement (-1), or no-improvement (0) groups based on change in clinician-rated Clinical Global Impressions-ADHD-Severity (CGI-ADHD-S) scores. Baseline-to-endpoint AAQoL total score mean (standard deviation [SD]) changes were calculated. The MCID was calculated as the difference in CGI-ADHD-S slightand no-improvement groups’ AAQoL total score mean changes. For the distribution-based approach, baseline-to-endpoint mean (SD) changes in AAQoL scores corresponding to 0.5 SD were computed. Results: Baseline-to-endpoint AAQoL mean (SD) changes in the much-, slight-, and noimprovement groups with short-term treatment were 21.31(17.11), 12.38(13.75), and 4.30(12.24), respectively, and with long-term treatment were 23.84(16.41), 11.21(12.56), and 2.83(11.30), respectively. With short- and long-term treatment, the MCID was 8.08 and 8.37 points, respectively, and the criterion of 0.5 SD was equivalent to a 7.89- and 8.05-point improvement, respectively. In responders (≥0.5 SD on AAQoL), respective baseline-to-endpoint AAQoL mean (standard error) changes for atomoxetine vs. placebo in the slight-improvement group following short-term treatment were 20.5(1.0) vs. 21.3(1.5) and following long-term treatment were 19.7(0.9) vs. 18.9(1.2). Conclusion(s): These results suggest that a MCID of approximately 8 points on the AAQoL is a clinically relevant improvement in quality of life and that the distribution- and anchor-based methodologies are equivalent when estimating MCID. Keywords: attention deficit/hyperactivity disorder, ADHD, atomoxetine
www.wpamadrid2014.com
ABSTRACTS BOOK
13
XVI World Congress of Psychiatry. Madrid 2014
VOL. 1 - TOPIC 1: ADHD
NEUROIMAGING IN KORSAKOFF SYNDROME C. Lopez , MJ. Sanchez , I. Martinez University Hospital Guadalajara, Spain.
Korsakoff syndrome is characterised by a serious anterograde and retrograde amnesia. The biggest problem is the inability to form new memories and variable gaps from previous events, which represents a disconnection from reality and feel new experiences every minute. Chronic abnormalities identified with neuroimaging allow exam the brain damage in patients with Korsakoff syndrome and could explain the neuropsychological deficits resulting from thiamine deficiency and alcohol neurotoxicity. We report the case of a patient diagnosed of Wernicke's encephalopathy who kept daily alcohol consumption with consequent cerebral degeneration.
www.wpamadrid2014.com
ABSTRACTS BOOK
14
XVI World Congress of Psychiatry. Madrid 2014ASTHMA AND ATTENTION-DEFICIT VOL. 1 - TOPIC 1: ADHD ASSOCIATION BETWEEN HYPERACTIVITY DISORDERS IN CHILDREN: POTENTIAL RISK FACTORS
Abdulbari Bener 1,2, Mohammad S. Ehlayel 3,4, Hale Zeynep Bener 1 1
Dept. of Medical Statistics and Epidemiology, Hamad Medical Corporation, Dept. of Public Health, Weill Cornell Medical College, Qatar 2 Depart. Evidence for Population Health Unit, The University of Manchester, Manchester, UK 3 Dept. of Pediatrics, Weill Cornell Medical College & Hamad Medical Corporation, Qatar
Aim: The objective of this study was to investigate the prevalence of asthma among ADHD children. Methods: 520 children with asthma and ADHD and 520 controls aged 5-16 years old controls matched by age and ethnicity studied Hamad General Hospital, Rumeilah Hospital, School Health and Primary Health care Clinics, between June 2011 to September 2013 in Qatar. Data based questionnaire, clinical manifestations, family history, BMI, and clinical biochemistry variables including serum 25(OH) vitamin D, calcium, phosphorus, magnesium was obtained. Univariate and multivariate statistical analyses were performed. Results: The mean age (± SD, in years) for ADHD versus control subjects was 9.92±3.3 vs. 10.20±3.4. There was a significant difference found in the mean values (± SD, in ng/ml) of vitamin D between asthmatic with ADHD (17.25±10.53) and control children (23.91±9.82) (p
